SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

Conversations around SPY are intensely focused on a potential government shutdown and recent tariff threats, creating significant market uncertainty. Community discussions are split between strong bearish predictions for a market pullback and contrarian views anticipating resilience, especially with upcoming major tech earnings. Amidst these factors, precious metals like gold and silver are gaining attention as they reach new highs, reflecting broader concerns about market stability.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is a major talking point following a significant price retracement that has sharply divided the crypto community. Many express bearish views, labeling it a "scam" or "worthless" and suggesting a flight to gold and silver, with some attributing the drop to institutional selling and leveraged long liquidations. In contrast, staunch bulls are framing the current dip as a "bear trap" and a compelling "buy opportunity," maintaining confidence in a future rebound.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is trending due to an intensifying Arctic blast and widespread winter storm across the U.S., which is significantly increasing natural gas demand for heating and electricity. The community is actively discussing the potential for further price movements, balancing immediate demand surges and possible production freeze-offs against concerns about power outages reducing consumption and the inherent volatility of natural gas markets.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to a significant US government investment package, including an equity stake and substantial funding, aimed at strengthening domestic critical mineral supply chains. This strategic move is generating widespread bullish sentiment and community speculation about a considerable price surge for the stock. While many anticipate significant upward momentum, some discussions revolve around the specifics of the valuation and potential short-term volatility.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

ProShares UltraShort Bloomberg Natural Gas (KOLD) is trending amid extreme volatility in natural gas markets, fueled by severe winter weather across the U.S. and discussions around potential production impacts and LNG export changes. The community is sharply divided, debating whether the current cold snap and its effects are already priced into natural gas, leading to intense speculation on KOLD's rebound against its inverse counterpart, BOIL, or if further downside is expected.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is drawing significant attention following progress in Tecarfarin's manufacturing and new research emphasizing its potential for LVAD patients, complemented by a strategic pipeline acquisition. The community is actively debating its future as a novel anticoagulant with FDA designations and an Abbott collaboration, contrasting this optimism with concerns over financing and perceived promotional activity.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

UNG is experiencing extreme volatility as a severe winter storm across the U.S. drives an unprecedented surge in natural gas demand and prices. The community is sharply divided, with many expecting continued gains due to the intense cold, while others caution that the rally is overextended and "priced in," anticipating a significant pullback. This high-stakes environment reflects natural gas's reputation as a "widowmaker" among traders.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Gold (GLD) is seeing significant trending activity as its price reaches record levels, fueled by heightened global geopolitical tensions and a perceived weakening of the dollar. Community sentiment is polarized, with many touting its role as a critical safe haven and a beneficiary of central bank diversification, while a vocal segment expresses concerns about its rapid ascent being "overbought." This market activity sparks broader conversations around shifts in global asset allocation and monetary stability.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

The biotech sector, represented by LABU, is experiencing robust upward momentum, largely driven by market optimism surrounding potential Federal Reserve rate cuts and the transformative impact of AI on drug discovery. This rally is further amplified by ongoing significant buyout activities within the sector, sparking widespread community discussion about a substantial recovery and capital rotation into biotech, despite some expressing caution regarding its rapid ascent.

Darling Ingredients, Inc. engages in the development and production of natural ingredients from edible and inedible bio-nutrients. It operates through the following segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients. The Feed Ingredients segment includes ingredients such as fats and proteins used cooking oil, trap grease and food residuals collection, the Rothsay ingredients, and specialty products. The Food Ingredients segment consists of gelatin, natural casings and meat by-products, and specialty products activities. The Fuel Ingredients segment includes the bioenergy business. The company was founded in 1882 and is headquartered in Irving, TX.

Darling Ingredients Inc

Darling Ingredients is currently trending due to its Diamond Green Diesel (DGD) joint venture's approval of a significant Sustainable Aviation Fuel (SAF) project, which has ignited strong community interest and analyst upgrades. This strategic move highlights the company's leadership in the renewable energy transition and its broader portfolio of sustainable solutions.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rapport Therapeutics (NASDAQ:RAPP) Upgraded to Hold at Wall Street Zen

Wall Street Zen raised Rapport Therapeutics from a "sell" rating to a "hold" rating in a research note on Sunday...

Abraham Ceesay Sells 5,833 Shares of Rapport Therapeutics (NASDAQ:RAPP) Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) CEO Abraham Ceesay sold 5,833 shares of Rapport Therapeutics stock in a transaction that occurred on Tuesday, January 20th. The stock was...

Rapport Therapeutics, Inc. (NASDAQ:RAPP) Short Interest Up 20.7% in December

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totaling 2,692,137...

Rapport Therapeutics, Inc. (NASDAQ:RAPP) Given Average Rating of "Moderate Buy" by Analysts

Shares of Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eight analysts that are presently covering the firm, Marketbeat...

Rapport Therapeutics (NASDAQ:RAPP) Downgraded by Wall Street Zen to "Sell"

Wall Street Zen lowered Rapport Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...

Rapport Therapeutics (NASDAQ:RAPP) Insider David Bredt Sells 8,500 Shares

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider David Bredt sold 8,500 shares of the stock in a transaction that occurred on Thursday, January 15th. The shares were sold at an...

Rapport Therapeutics (NASDAQ:RAPP) Trading Down 6.9% - Time to Sell?

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 6.9% - What's Next...

Insider Selling: Rapport Therapeutics (NASDAQ:RAPP) Insider Sells 2,840 Shares of Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider Krishnaswamy Yeleswaram sold 2,840 shares of Rapport Therapeutics stock in a transaction on Wednesday, December 31st. The shares...

Krishnaswamy Yeleswaram Sells 2,840 Shares of Rapport Therapeutics (NASDAQ:RAPP) Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider Krishnaswamy Yeleswaram sold 2,840 shares of the firm's stock in a transaction dated Wednesday, December 31st. The shares were sold...

Rapport Therapeutics (NASDAQ:RAPP) Insider Sells $197,338.35 in Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider David Bredt sold 6,567 shares of the business's stock in a transaction on Wednesday, December 31st. The stock was sold at an average...

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

RAPP
Rapport Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RAPP News

RAPPRapport Therapeutics Inc